Steven Cohen Foghorn Therapeutics Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 399,702 shares of FHTX stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
399,702
Previous 406,641
1.71%
Holding current value
$1.67 Million
Previous $2.34 Million
59.15%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding FHTX
# of Institutions
84Shares Held
33.4MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$53.1 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$22.2 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$12.7 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.63 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$7.26 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $174M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...